KRAS and cancer: KRASG12C mutation (glycine-to-cysteine substitution at codon 12) is one of the most common KRAS mutations, and it may occur in a variety of tumor types, such as non-small-cell lung cancer (NSCLC), colorectal cancers (CRC), pancreatic cancers, and other cancers [6].